Tactile Systems Technology (NASDAQ:TCMD – Get Free Report)‘s stock had its “hold (c)” rating restated by analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.
Other equities research analysts have also issued reports about the company. Lake Street Capital initiated coverage on Tactile Systems Technology in a research note on Friday, October 3rd. They issued a “buy” rating and a $23.50 price objective for the company. B. Riley reaffirmed a “neutral” rating and issued a $13.00 price objective (up from $12.00) on shares of Tactile Systems Technology in a research note on Tuesday, August 5th. William Blair raised Tactile Systems Technology to a “strong-buy” rating in a research note on Tuesday, August 5th. Finally, Wall Street Zen raised Tactile Systems Technology from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $16.83.
View Our Latest Research Report on TCMD
Tactile Systems Technology Price Performance
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. Tactile Systems Technology had a return on equity of 7.72% and a net margin of 5.06%.The company had revenue of $78.91 million during the quarter, compared to analyst estimates of $73.93 million. Tactile Systems Technology has set its FY 2025 guidance at EPS. On average, research analysts expect that Tactile Systems Technology will post 0.7 EPS for the current fiscal year.
Insider Buying and Selling at Tactile Systems Technology
In other news, CEO Sheri Louise Dodd sold 7,762 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $12.36, for a total value of $95,938.32. Following the sale, the chief executive officer directly owned 173,479 shares in the company, valued at approximately $2,144,200.44. This represents a 4.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 2.50% of the company’s stock.
Institutional Investors Weigh In On Tactile Systems Technology
Several hedge funds and other institutional investors have recently modified their holdings of TCMD. Acadian Asset Management LLC raised its holdings in shares of Tactile Systems Technology by 248.3% in the second quarter. Acadian Asset Management LLC now owns 683,662 shares of the company’s stock worth $6,930,000 after buying an additional 487,392 shares during the period. Federated Hermes Inc. increased its holdings in Tactile Systems Technology by 42.7% during the 2nd quarter. Federated Hermes Inc. now owns 551,561 shares of the company’s stock worth $5,593,000 after purchasing an additional 165,163 shares during the period. Norges Bank purchased a new position in Tactile Systems Technology during the 2nd quarter worth $1,464,000. Paradigm Capital Management Inc. NY increased its holdings in Tactile Systems Technology by 5.9% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,618,600 shares of the company’s stock worth $16,413,000 after purchasing an additional 89,600 shares during the period. Finally, Victory Capital Management Inc. purchased a new position in Tactile Systems Technology during the 1st quarter worth $1,160,000. 83.43% of the stock is currently owned by hedge funds and other institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Articles
- Five stocks we like better than Tactile Systems Technology
- Best Stocks Under $5.00
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- How to Calculate Return on Investment (ROI)
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.